Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Quarterly results
22nd Century Group, Inc. (XXII) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/18/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/18/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “..."
07/24/2023 8-K Quarterly results
07/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/07/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Form of Warrant",
"Opinion of Foley & Lardner LLP",
"Form of Securities Purchase Agreement, by and between 22nd Century Group, Inc. and each of the Purchasers (as defined therein)",
"22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market BUFFALO, N.Y., July 6, 2023 -- 22nd Century Group, Inc. , a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has entered into definitive agreements with certain investors for the purchase and sale of 778,634 shares of common stock and warrants at a price of $3.80 per share in a registered direct offering priced above market. Gross proceeds to the Company from the registered direct offering are expected to be $3.0 million, before deducting the placement agent’ s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for the conti..."
07/07/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “..."
04/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/25/2023 ARS Form ARS - Annual Report to Security Holders:
04/25/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/24/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
04/21/2023 8-K Quarterly results
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/05/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "22nd Century Group Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies"
04/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/31/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/31/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
03/28/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/10/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
03/10/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/10/2023 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "The unaudited pro forma condensed combined statement of operations and comprehensive loss for the year ended December 31, 2022 and the related notes thereto after giving effect to the Transaction (filed herewith)"
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
Docs: "Revenues, net $ 19,206 $ 7,960 $ 62,111 $ 30,948 Cost of goods sold 19,852 7,729 60,937 29,462 Gross profit 231 1,174 1,486 Operating expenses: Sales, general and administrative 14,097 8,058 44,517 25,908 Research and development 2,093 1,126 6,561 3,912 Other operating expense, net 6,322 78 7,202 78 Total operating expenses 22,512 9,262 58,280 29,898 Operating loss Other income : Unrealized loss on investments — Realized gain on Panacea investment — 2,548 Realized loss on short-term investment securities — — Other income, net 15 — 71 — Interest income, net 102 49 313 321 Interest expense Total other expense Loss before income taxes provision for income taxes 2,148 14 14 Net loss $ $ $ $ Net loss per common share - basic and diluted $ $ $ $ Weighted average common shares outstandin...",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “..."
02/10/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/24/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "22nd Century Group Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position"
11/21/2022 8-K Quarterly results
11/17/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTSThis presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “p..."
09/15/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy